The announcement of an upsized public offering indicates strong investor interest and a positive outlook for Apogee Therapeutics. This influx of capital is likely to support its operations and future projects, potentially leading to a positive short-term impact on its stock price. However, the actual impact could vary depending on market conditions and investor perceptions of the offering's value.